How Cells Control Gene Expression by Cleaning up Their Mistakes
Published:01 Nov.2024    Source:University of Chicago
New research from the University of Chicago suggests that alternative splicing may have an even greater influence on biology than just by creating new protein isoforms. The study shows that the biggest impact of alternative splicing may come via its role in regulating gene expression levels. The research team, led by Yang Li, PhD, Benjamin Fair, PhD, and Carlos Buen Abad Najar, PhD, analyzed large sets of genomic data, covering various stages from early transcription to when RNA transcripts are destroyed by the cell. They saw that cells produced three times as many "unproductive" transcripts -- RNA molecules with mistakes or unexpected configurations -- as when they analyzed steady-state, finished RNA only.
 
Unproductive transcripts are quickly destroyed by a cellular process called nonsense-mediated decay (NMD). Li's team calculated that on average, about 15% of transcripts that are started are almost immediately degraded by NMD; when they looked at genes with low expression levels, that number went up to 50%. "We think it's because NMD is so efficient," Li said. "The cell can afford to make mistakes without damaging things, so there's no selective pressure to make fewer mistakes." But Li suspected there must also be some purpose for such a widespread phenomenon. His team conducted a genome wide association study (GWAS) to compare gene expression levels across different cell lines. They found many variations at genetic locations that are known to affect the level of unproductive splicing. These loci were just as often associated with differences in genetic expression caused by NMD as they were with differences in production of multiple protein isoforms. Li believes cells sometimes purposely select transcripts doomed for NMD to decrease expression levels.
 
The team found that many variants linked to complex diseases are also associated with more unproductive splicing and decreased gene expression. So, they believe that better understanding its impact could help develop new treatments that leverage the alternative splicing-NMD process. "We think we can target a lot of genes because now we know how much this process is going on," Li said. "People used to think that alternative splicing was mainly a way to make an organism more complex by generating different versions of proteins. Now we're showing that it might not be its most important function. It could be simply to control gene expression."